A placebo-controlled, double-blind, randomized, single dose, dose escalating trial in healthy men to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SPC3649.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
64
PhaseOne Trials, Hvidovre University Hospital
Hvidovre, Denmark
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.